In this open, monocentric, observational study acute coronary syndrom (ACS) patients will be characterized by pneumological examination concerning a concomitant chronic obstructive pulmonary disease (COPD). Often COPD coexists with ACS; therefore ACS patients benefit either from prevention or potential therapy of chronic hypoxia.
In this study patients with either non ST-segment-elevation myocardial infarction (NSTEMI) or ST-segment-elevation myocardial infarction (STEMI) will be included. After amnesis patients will undergo blood withdrawal, blood-gas analysis and examinations concerning pulmonary function (Bodyplethysmography). In addition to routine blood withdrawal for differential blood count, 9 ml blood sample is takenfor molecular analysis of relevant prognostic chronic obstructive pulmonary disease (COPD)-blood based biomarkers, an for establishing a library of biomaterial in form of a biobank.
Study Type
OBSERVATIONAL
Enrollment
100
Amrei Pelzer
Aachen, North Rhine-Westphalia, Germany
Number of patients with Acute Coronary Syndrom (ACS) and concomitant Chronic Obstructive Pulmonary Disease (COPD)
Time frame: During 1-2 hours (at time of examination)
Molecular analysis of relevant blood based chronic obstructive pulmonary disease (COPD) biomarkers
Time frame: An average of 1 day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.